DEVELOPING CUTTING EDGE ORGANOID TECHNOLOGIES TO ENABLE ADVANCED THERAPEUTICS
State-of-the-art stem cell technology to enhance translational research and expand the number of human organoid models available to support research in Australia.
Stem cell research provides an exciting model and tool for numerous areas of research. The facility offers a range of custom iPSC services including organoid model systems to increase the scope of stem cell research at CMRI and affiliated Institutions.
Our goal is to create a broadly available resource of human iPS cells-derived products and derivative tissues to accelerate research.
Pluripotent stem cells, including embryonic and induced pluripotent stem (iPS) cells, are undifferentiated cells that can differentiate into any cell type in the human body. They can survive and replicate indefinitely in the dish providing an unlimited source of cells for regenerative medicine, modelling diseases and development of new therapeutic approaches. For example, large numbers of drugs can be tested to find suitable treatments; this is called drug screening.
The Stem Cell and Organoid Facility operates on a fee-for-service basis to provide researchers with customised iPSC generation and differentiated cell types, including 3D organoids.
Reprogramming, expansion, characterisation, and banking of iPS cells.
Maintenance of reprogrammed iPS cell lines.
Differentiation of iPS cell lines into a number of tissues and organoids.
Access to micro-electrode array (MEA) technology
Discover our Stem Cell teams best publications.
CMRI has a number of core facilities that complement the services provided by the Stem Cell & Organoid Facility. We aim to provide a comprehensive range of services to facilitate all aspects of customers' research.
Learn more about partnership opportunities and how stem cell technology can transform translational research.
The Stem Cell & Organoid Facility is proudly supported by Luminesce Alliance and NSW Government, as well as Children's Medical Research Institute.